{"SLR NAME":"Meta-analysis of sociodemographic and clinical risk factors, laboratory parameters and treatments associated with higher mortality in COVID-19.","References":[{"title1":"Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study","References":[{"title2":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China","References":[{"title3":"The%20epidemiological%20characteristics%20of%20an%20outbreak%20of%202019%20novel%20coronavirus%20diseases%20(COVID-19)%20in%20China"}]},{"title2":"Novel coronavirus (2019-nCoV)","References":[{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"}]},{"title2":"Novel coronavirus (2019-nCoV)","References":[{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"},{"title3":"Novel%20coronavirus%20(2019-nCoV)"}]},{"title2":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","References":[{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"},{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"},{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"},{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"},{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"}]},{"title2":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"}]},{"title2":"Clinical Characteristics of Coronavirus Disease 2019 in China","References":[{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"}]},{"title2":"Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"}]},{"title2":"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China","References":[]},{"title2":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","References":[]},{"title2":"Editorial Concern-Possible Reporting of the Same Patients With COVID-19 in Different Reports","References":[]},{"title2":"Diagnosis and treatment protocols of pneumonia caused by a novel coronavirus (trial version 6)","References":[]},{"title2":"Diagnosis and treatment protocols of pneumonia caused by a novel coronavirus (trial version 7)","References":[]},{"title2":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected","References":[]},{"title2":"IMAI district clinician manual: hospital care adolescents and adults: guidelines for the management of illnessess with limited-resources","References":[]},{"title2":"Radiographic-clinical correlation in severe acute respiratory syndrome: study of 1373 patients in Hong Kong","References":[]},{"title2":"Clinical implication of radiographic scores in acute Middle East respiratory syndrome coronavirus pneumonia: Report from a single tertiary-referral center of South Korea","References":[{"title3":"Clinical%20implication%20of%20radiographic%20scores%20in%20acute%20Middle%20East%20respiratory%20syndrome%20coronavirus%20pneumonia:%20Report%20from%20a%20single%20tertiary-referral%20center%20of%20South%20Korea"},{"title3":"Clinical%20implication%20of%20radiographic%20scores%20in%20acute%20Middle%20East%20respiratory%20syndrome%20coronavirus%20pneumonia:%20Report%20from%20a%20single%20tertiary-referral%20center%20of%20South%20Korea"},{"title3":"Clinical%20implication%20of%20radiographic%20scores%20in%20acute%20Middle%20East%20respiratory%20syndrome%20coronavirus%20pneumonia:%20Report%20from%20a%20single%20tertiary-referral%20center%20of%20South%20Korea"},{"title3":"Clinical%20implication%20of%20radiographic%20scores%20in%20acute%20Middle%20East%20respiratory%20syndrome%20coronavirus%20pneumonia:%20Report%20from%20a%20single%20tertiary-referral%20center%20of%20South%20Korea"},{"title3":"Clinical%20implication%20of%20radiographic%20scores%20in%20acute%20Middle%20East%20respiratory%20syndrome%20coronavirus%20pneumonia:%20Report%20from%20a%20single%20tertiary-referral%20center%20of%20South%20Korea"},{"title3":"Clinical%20implication%20of%20radiographic%20scores%20in%20acute%20Middle%20East%20respiratory%20syndrome%20coronavirus%20pneumonia:%20Report%20from%20a%20single%20tertiary-referral%20center%20of%20South%20Korea"},{"title3":"Clinical%20implication%20of%20radiographic%20scores%20in%20acute%20Middle%20East%20respiratory%20syndrome%20coronavirus%20pneumonia:%20Report%20from%20a%20single%20tertiary-referral%20center%20of%20South%20Korea"},{"title3":"Clinical%20implication%20of%20radiographic%20scores%20in%20acute%20Middle%20East%20respiratory%20syndrome%20coronavirus%20pneumonia:%20Report%20from%20a%20single%20tertiary-referral%20center%20of%20South%20Korea"},{"title3":"Clinical%20implication%20of%20radiographic%20scores%20in%20acute%20Middle%20East%20respiratory%20syndrome%20coronavirus%20pneumonia:%20Report%20from%20a%20single%20tertiary-referral%20center%20of%20South%20Korea"},{"title3":"Clinical%20implication%20of%20radiographic%20scores%20in%20acute%20Middle%20East%20respiratory%20syndrome%20coronavirus%20pneumonia:%20Report%20from%20a%20single%20tertiary-referral%20center%20of%20South%20Korea"},{"title3":"Clinical%20implication%20of%20radiographic%20scores%20in%20acute%20Middle%20East%20respiratory%20syndrome%20coronavirus%20pneumonia:%20Report%20from%20a%20single%20tertiary-referral%20center%20of%20South%20Korea"},{"title3":"Clinical%20implication%20of%20radiographic%20scores%20in%20acute%20Middle%20East%20respiratory%20syndrome%20coronavirus%20pneumonia:%20Report%20from%20a%20single%20tertiary-referral%20center%20of%20South%20Korea"},{"title3":"Clinical%20implication%20of%20radiographic%20scores%20in%20acute%20Middle%20East%20respiratory%20syndrome%20coronavirus%20pneumonia:%20Report%20from%20a%20single%20tertiary-referral%20center%20of%20South%20Korea"},{"title3":"Clinical%20implication%20of%20radiographic%20scores%20in%20acute%20Middle%20East%20respiratory%20syndrome%20coronavirus%20pneumonia:%20Report%20from%20a%20single%20tertiary-referral%20center%20of%20South%20Korea"},{"title3":"Clinical%20implication%20of%20radiographic%20scores%20in%20acute%20Middle%20East%20respiratory%20syndrome%20coronavirus%20pneumonia:%20Report%20from%20a%20single%20tertiary-referral%20center%20of%20South%20Korea"},{"title3":"Clinical%20implication%20of%20radiographic%20scores%20in%20acute%20Middle%20East%20respiratory%20syndrome%20coronavirus%20pneumonia:%20Report%20from%20a%20single%20tertiary-referral%20center%20of%20South%20Korea"},{"title3":"Clinical%20implication%20of%20radiographic%20scores%20in%20acute%20Middle%20East%20respiratory%20syndrome%20coronavirus%20pneumonia:%20Report%20from%20a%20single%20tertiary-referral%20center%20of%20South%20Korea"},{"title3":"Clinical%20implication%20of%20radiographic%20scores%20in%20acute%20Middle%20East%20respiratory%20syndrome%20coronavirus%20pneumonia:%20Report%20from%20a%20single%20tertiary-referral%20center%20of%20South%20Korea"}]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition","References":[]},{"title2":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance","References":[]},{"title2":"Variance Inflation Factor: As a Condition for the Inclusion of Suppressor Variable(s) in Regression Analysis","References":[]},{"title2":"Portable chest X-ray in coronavirus disease-19 (COVID-19): A pictorial review","References":[{"title3":"Portable%20chest%20X-ray%20in%20coronavirus%20disease-19%20(COVID-19):%20A%20pictorial%20review"},{"title3":"Portable%20chest%20X-ray%20in%20coronavirus%20disease-19%20(COVID-19):%20A%20pictorial%20review"},{"title3":"Portable%20chest%20X-ray%20in%20coronavirus%20disease-19%20(COVID-19):%20A%20pictorial%20review"},{"title3":"Portable%20chest%20X-ray%20in%20coronavirus%20disease-19%20(COVID-19):%20A%20pictorial%20review"},{"title3":"Portable%20chest%20X-ray%20in%20coronavirus%20disease-19%20(COVID-19):%20A%20pictorial%20review"},{"title3":"Portable%20chest%20X-ray%20in%20coronavirus%20disease-19%20(COVID-19):%20A%20pictorial%20review"},{"title3":"Portable%20chest%20X-ray%20in%20coronavirus%20disease-19%20(COVID-19):%20A%20pictorial%20review"},{"title3":"Portable%20chest%20X-ray%20in%20coronavirus%20disease-19%20(COVID-19):%20A%20pictorial%20review"},{"title3":"Portable%20chest%20X-ray%20in%20coronavirus%20disease-19%20(COVID-19):%20A%20pictorial%20review"},{"title3":"Portable%20chest%20X-ray%20in%20coronavirus%20disease-19%20(COVID-19):%20A%20pictorial%20review"},{"title3":"Portable%20chest%20X-ray%20in%20coronavirus%20disease-19%20(COVID-19):%20A%20pictorial%20review"}]},{"title2":"Lung Ultrasound in the Diagnosis and Follow-up of Community-Acquired Pneumonia: A Prospective, Multicenter, Diagnostic Accuracy Study","References":[]},{"title2":"Lung ultrasound for the diagnosis of pneumonia in adults: a systematic review and meta-analysis","References":[]},{"title2":"A gross observational report of systematic autopsy in COVID-19 pneumonia","References":[]},{"title2":"Endothelial-platelet interactions in influenza-induced pneumonia: A potential therapeutic target","References":[]},{"title2":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","References":[{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"}]},{"title2":"[Study on the levels of main inflammatory factors in septic shock and their clinical significance]","References":[]},{"title2":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","References":[{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"}]},{"title2":"Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: Longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients","References":[]},{"title2":"Neutrophil Activation During Septic Shock","References":[{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"},{"title3":"Neutrophil%20Activation%20During%20Septic%20Shock"}]},{"title2":"The association between plasma D-dimer levels and community-acquired pneumonia","References":[{"title3":"The%20association%20between%20plasma%20D-dimer%20levels%20and%20community-acquired%20pneumonia"},{"title3":"The%20association%20between%20plasma%20D-dimer%20levels%20and%20community-acquired%20pneumonia"},{"title3":"The%20association%20between%20plasma%20D-dimer%20levels%20and%20community-acquired%20pneumonia"},{"title3":"The%20association%20between%20plasma%20D-dimer%20levels%20and%20community-acquired%20pneumonia"},{"title3":"The%20association%20between%20plasma%20D-dimer%20levels%20and%20community-acquired%20pneumonia"},{"title3":"The%20association%20between%20plasma%20D-dimer%20levels%20and%20community-acquired%20pneumonia"},{"title3":"The%20association%20between%20plasma%20D-dimer%20levels%20and%20community-acquired%20pneumonia"},{"title3":"The%20association%20between%20plasma%20D-dimer%20levels%20and%20community-acquired%20pneumonia"},{"title3":"The%20association%20between%20plasma%20D-dimer%20levels%20and%20community-acquired%20pneumonia"},{"title3":"The%20association%20between%20plasma%20D-dimer%20levels%20and%20community-acquired%20pneumonia"},{"title3":"The%20association%20between%20plasma%20D-dimer%20levels%20and%20community-acquired%20pneumonia"},{"title3":"The%20association%20between%20plasma%20D-dimer%20levels%20and%20community-acquired%20pneumonia"},{"title3":"The%20association%20between%20plasma%20D-dimer%20levels%20and%20community-acquired%20pneumonia"},{"title3":"The%20association%20between%20plasma%20D-dimer%20levels%20and%20community-acquired%20pneumonia"},{"title3":"The%20association%20between%20plasma%20D-dimer%20levels%20and%20community-acquired%20pneumonia"},{"title3":"The%20association%20between%20plasma%20D-dimer%20levels%20and%20community-acquired%20pneumonia"},{"title3":"The%20association%20between%20plasma%20D-dimer%20levels%20and%20community-acquired%20pneumonia"},{"title3":"The%20association%20between%20plasma%20D-dimer%20levels%20and%20community-acquired%20pneumonia"},{"title3":"The%20association%20between%20plasma%20D-dimer%20levels%20and%20community-acquired%20pneumonia"},{"title3":"The%20association%20between%20plasma%20D-dimer%20levels%20and%20community-acquired%20pneumonia"},{"title3":"The%20association%20between%20plasma%20D-dimer%20levels%20and%20community-acquired%20pneumonia"}]},{"title2":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia]","References":[]}]},{"title1":"Sociodemographic, clinical and laboratory factors on admission associated with COVID-19 mortality in hospitalized patients: A retrospective observational study","References":[{"title2":"Ministerio de Sanidad. Gobierno de Espana. Situacion de COVID-19 en Espana. Incidencia acumulada en los ultimos 14 dias. 2020; https://covid19.isciii.es/","References":[]},{"title2":"Ministerio de Sanidad. Gobierno de Espana. Actualizacion n  86. Enfermedad por el coronavirus (COVID-19). 2020; https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Actualizacion_86_COVID-19.pdf","References":[]},{"title2":"Ministerio de Sanidad. Gobierno de Espana. Actualizacion n  85. Enfermedad por el coronavirus (COVID-19). 2020; https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Actualizacion_85_COVID-19.pdf","References":[]},{"title2":"Clinical Characteristics of Coronavirus Disease 2019 in China","References":[{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"},{"title3":"Clinical%20Characteristics%20of%20Coronavirus%20Disease%202019%20in%20China"}]},{"title2":"Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths","References":[{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"},{"title3":"Asymptomatic%20carrier%20state,%20acute%20respiratory%20disease,%20and%20pneumonia%20due%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20(SARS-CoV-2):%20Facts%20and%20myths"}]},{"title2":"Informe sobre la situacion de COVID-19 en Espana. Informe de COVID-19 n  21. Red Nacional de Vigilancia Epidemiologica. 2020; https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Documents/INFORMES/Informes%20COVID19/Informe%20n %2021.%20Situacion%20de%20COVID19%20en%20Espana%20a%206%20de%20abril%20de%202020.pdf","References":[]},{"title2":"World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020; https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf","References":[]},{"title2":"Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"Imaging Profile of the COVID-19 Infection: Radiologic Findings and Literature Review","References":[{"title3":"Imaging%20Profile%20of%20the%20COVID-19%20Infection:%20Radiologic%20Findings%20and%20Literature%20Review"},{"title3":"Imaging%20Profile%20of%20the%20COVID-19%20Infection:%20Radiologic%20Findings%20and%20Literature%20Review"},{"title3":"Imaging%20Profile%20of%20the%20COVID-19%20Infection:%20Radiologic%20Findings%20and%20Literature%20Review"},{"title3":"Imaging%20Profile%20of%20the%20COVID-19%20Infection:%20Radiologic%20Findings%20and%20Literature%20Review"},{"title3":"Imaging%20Profile%20of%20the%20COVID-19%20Infection:%20Radiologic%20Findings%20and%20Literature%20Review"},{"title3":"Imaging%20Profile%20of%20the%20COVID-19%20Infection:%20Radiologic%20Findings%20and%20Literature%20Review"},{"title3":"Imaging%20Profile%20of%20the%20COVID-19%20Infection:%20Radiologic%20Findings%20and%20Literature%20Review"},{"title3":"Imaging%20Profile%20of%20the%20COVID-19%20Infection:%20Radiologic%20Findings%20and%20Literature%20Review"},{"title3":"Imaging%20Profile%20of%20the%20COVID-19%20Infection:%20Radiologic%20Findings%20and%20Literature%20Review"},{"title3":"Imaging%20Profile%20of%20the%20COVID-19%20Infection:%20Radiologic%20Findings%20and%20Literature%20Review"},{"title3":"Imaging%20Profile%20of%20the%20COVID-19%20Infection:%20Radiologic%20Findings%20and%20Literature%20Review"},{"title3":"Imaging%20Profile%20of%20the%20COVID-19%20Infection:%20Radiologic%20Findings%20and%20Literature%20Review"},{"title3":"Imaging%20Profile%20of%20the%20COVID-19%20Infection:%20Radiologic%20Findings%20and%20Literature%20Review"}]},{"title2":"Dynamic basic reproduction number-based evaluation for current prevention and control of COVID-19 outbreak in China","References":[]},{"title2":"CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)","References":[{"title3":"CT%20Imaging%20Features%20of%202019%20Novel%20Coronavirus%20(2019-nCoV)"},{"title3":"CT%20Imaging%20Features%20of%202019%20Novel%20Coronavirus%20(2019-nCoV)"},{"title3":"CT%20Imaging%20Features%20of%202019%20Novel%20Coronavirus%20(2019-nCoV)"},{"title3":"CT%20Imaging%20Features%20of%202019%20Novel%20Coronavirus%20(2019-nCoV)"},{"title3":"CT%20Imaging%20Features%20of%202019%20Novel%20Coronavirus%20(2019-nCoV)"},{"title3":"CT%20Imaging%20Features%20of%202019%20Novel%20Coronavirus%20(2019-nCoV)"},{"title3":"CT%20Imaging%20Features%20of%202019%20Novel%20Coronavirus%20(2019-nCoV)"},{"title3":"CT%20Imaging%20Features%20of%202019%20Novel%20Coronavirus%20(2019-nCoV)"},{"title3":"CT%20Imaging%20Features%20of%202019%20Novel%20Coronavirus%20(2019-nCoV)"},{"title3":"CT%20Imaging%20Features%20of%202019%20Novel%20Coronavirus%20(2019-nCoV)"},{"title3":"CT%20Imaging%20Features%20of%202019%20Novel%20Coronavirus%20(2019-nCoV)"},{"title3":"CT%20Imaging%20Features%20of%202019%20Novel%20Coronavirus%20(2019-nCoV)"},{"title3":"CT%20Imaging%20Features%20of%202019%20Novel%20Coronavirus%20(2019-nCoV)"},{"title3":"CT%20Imaging%20Features%20of%202019%20Novel%20Coronavirus%20(2019-nCoV)"}]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"}]},{"title2":"Ministerio de sanidad. Gobierno de Espana. Informacion cientifico-tecnica. Enfermedad por coronavirus, COVID-19. 2020; https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertas%20Actual/nCov-China/documentos/20200404_ITCoronavirus.pdf","References":[]},{"title2":"Clinical and immunologic features in severe and moderate coronavirus disease 2019","References":[]},{"title2":"Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"}]},{"title2":"Clinical outcomes of current medical approaches for Middle East respiratory syndrome: A systematic review and meta-analysis","References":[{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20A%20systematic%20review%20and%20meta-analysis"}]},{"title2":"Prognostication in severe acute respiratory syndrome: a retrospective time-course analysis of 1312 laboratory-confirmed patients in Hong Kong","References":[{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"},{"title3":"Prognostication%20in%20severe%20acute%20respiratory%20syndrome:%20a%20retrospective%20time-course%20analysis%20of%201312%20laboratory-confirmed%20patients%20in%20Hong%20Kong"}]},{"title2":"StataCorp. 2017. Stata Statistical Software: Release 15. College Station, TX: StataCorp LLC.","References":[]},{"title2":"Centro Nacional de Epidemiologia. Red Nacional de Vigilancia Epidemiologica. Informe sobre la situacion de COVID-19 en Espana. Informe 14. 2020; https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Documents/INFORMES/Informes%20COVID19/Informe%20n%C2%BA%2014.%20Situaci%C3%B3n%20de%20COVID19%20en%20Espa%C3%B1a%20a%2024%20marzo%20de%202020.pdf","References":[]},{"title2":"Demographic science aids in understanding the spread and fatality rates of COVID-19","References":[{"title3":"Demographic%20science%20aids%20in%20understanding%20the%20spread%20and%20fatality%20rates%20of%20COVID-19"},{"title3":"Demographic%20science%20aids%20in%20understanding%20the%20spread%20and%20fatality%20rates%20of%20COVID-19"},{"title3":"Demographic%20science%20aids%20in%20understanding%20the%20spread%20and%20fatality%20rates%20of%20COVID-19"},{"title3":"Demographic%20science%20aids%20in%20understanding%20the%20spread%20and%20fatality%20rates%20of%20COVID-19"},{"title3":"Demographic%20science%20aids%20in%20understanding%20the%20spread%20and%20fatality%20rates%20of%20COVID-19"},{"title3":"Demographic%20science%20aids%20in%20understanding%20the%20spread%20and%20fatality%20rates%20of%20COVID-19"},{"title3":"Demographic%20science%20aids%20in%20understanding%20the%20spread%20and%20fatality%20rates%20of%20COVID-19"},{"title3":"Demographic%20science%20aids%20in%20understanding%20the%20spread%20and%20fatality%20rates%20of%20COVID-19"}]},{"title2":"The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19). China CDC Wkly, 2020; http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51","References":[]},{"title2":"Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"}]},{"title2":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","References":[]},{"title2":"Ministerio de Sanidad. Gobierno de Espana. Informacion cientifico-tecnica. Enfermedad por coronavirus, COVID-19. 2020; https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/20200417_ITCoronavirus.pdf","References":[]},{"title2":"Prevalence and duration of acute loss of smell or taste in COVID-19 patients","References":[{"title3":"Prevalence%20and%20duration%20of%20acute%20loss%20of%20smell%20or%20taste%20in%20COVID-19%20patients"},{"title3":"Prevalence%20and%20duration%20of%20acute%20loss%20of%20smell%20or%20taste%20in%20COVID-19%20patients"},{"title3":"Prevalence%20and%20duration%20of%20acute%20loss%20of%20smell%20or%20taste%20in%20COVID-19%20patients"},{"title3":"Prevalence%20and%20duration%20of%20acute%20loss%20of%20smell%20or%20taste%20in%20COVID-19%20patients"}]},{"title2":"Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics","References":[{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"},{"title3":"Olfactory%20Dysfunction%20and%20Sinonasal%20Symptomatology%20in%20COVID-19:%20Prevalence,%20Severity,%20Timing,%20and%20Associated%20Characteristics"}]},{"title2":"Tobacco smoking and COVID-19 pandemic: old and new issues. A summary of the evidence from the scientific literature","References":[{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"},{"title3":"Tobacco%20smoking%20and%20COVID-19%20pandemic:%20old%20and%20new%20issues.%20A%20summary%20of%20the%20evidence%20from%20the%20scientific%20literature"}]},{"title2":"COVID-19 and smoking: A systematic review of the evidence","References":[{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"},{"title3":"COVID-19%20and%20smoking:%20A%20systematic%20review%20of%20the%20evidence"}]},{"title2":"Predictors of Mortality for Patients with COVID-19 Pneumonia Caused by SARS-CoV-2: A Prospective Cohort Study","References":[]},{"title2":"COVID-19 Spiraling of Frailty in Older Italian Patients","References":[{"title3":"COVID-19%20Spiraling%20of%20Frailty%20in%20Older%20Italian%20Patients"},{"title3":"COVID-19%20Spiraling%20of%20Frailty%20in%20Older%20Italian%20Patients"},{"title3":"COVID-19%20Spiraling%20of%20Frailty%20in%20Older%20Italian%20Patients"},{"title3":"COVID-19%20Spiraling%20of%20Frailty%20in%20Older%20Italian%20Patients"},{"title3":"COVID-19%20Spiraling%20of%20Frailty%20in%20Older%20Italian%20Patients"},{"title3":"COVID-19%20Spiraling%20of%20Frailty%20in%20Older%20Italian%20Patients"},{"title3":"COVID-19%20Spiraling%20of%20Frailty%20in%20Older%20Italian%20Patients"},{"title3":"COVID-19%20Spiraling%20of%20Frailty%20in%20Older%20Italian%20Patients"},{"title3":"COVID-19%20Spiraling%20of%20Frailty%20in%20Older%20Italian%20Patients"},{"title3":"COVID-19%20Spiraling%20of%20Frailty%20in%20Older%20Italian%20Patients"},{"title3":"COVID-19%20Spiraling%20of%20Frailty%20in%20Older%20Italian%20Patients"},{"title3":"COVID-19%20Spiraling%20of%20Frailty%20in%20Older%20Italian%20Patients"},{"title3":"COVID-19%20Spiraling%20of%20Frailty%20in%20Older%20Italian%20Patients"},{"title3":"COVID-19%20Spiraling%20of%20Frailty%20in%20Older%20Italian%20Patients"},{"title3":"COVID-19%20Spiraling%20of%20Frailty%20in%20Older%20Italian%20Patients"},{"title3":"COVID-19%20Spiraling%20of%20Frailty%20in%20Older%20Italian%20Patients"},{"title3":"COVID-19%20Spiraling%20of%20Frailty%20in%20Older%20Italian%20Patients"},{"title3":"COVID-19%20Spiraling%20of%20Frailty%20in%20Older%20Italian%20Patients"}]},{"title2":"Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19)-United States, February 12-March 16, 2020","References":[]},{"title2":"Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea","References":[{"title3":"Epidemiologic%20characteristics%20of%20early%20cases%20with%202019%20novel%20coronavirus%20(2019-nCoV)%20disease%20in%20Korea"},{"title3":"Epidemiologic%20characteristics%20of%20early%20cases%20with%202019%20novel%20coronavirus%20(2019-nCoV)%20disease%20in%20Korea"},{"title3":"Epidemiologic%20characteristics%20of%20early%20cases%20with%202019%20novel%20coronavirus%20(2019-nCoV)%20disease%20in%20Korea"},{"title3":"Epidemiologic%20characteristics%20of%20early%20cases%20with%202019%20novel%20coronavirus%20(2019-nCoV)%20disease%20in%20Korea"},{"title3":"Epidemiologic%20characteristics%20of%20early%20cases%20with%202019%20novel%20coronavirus%20(2019-nCoV)%20disease%20in%20Korea"},{"title3":"Epidemiologic%20characteristics%20of%20early%20cases%20with%202019%20novel%20coronavirus%20(2019-nCoV)%20disease%20in%20Korea"}]},{"title2":"Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis","References":[]},{"title2":"Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy","References":[]},{"title2":"Unos 12.190 ancianos muertos en residencias de Espana con diagnostico o sintomas de coronavirus. El independiente, 2020. Available from: https://www.elindependiente.com/vida-sana/2020/04/17/cerca-de-12-190-ancianos-han-muerto-en-las-residencias-de-espana-con-diagnostico-o-sintomas-de-covid-19/","References":[]},{"title2":"Rapid Progression to Acute Respiratory Distress Syndrome: Review of Current Understanding of Critical Illness From COVID-19 Infection","References":[]},{"title2":"Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up","References":[{"title3":"Coronavirus%20disease%202019%20in%20elderly%20patients:%20Characteristics%20and%20prognostic%20factors%20based%20on%204-week%20follow-up"},{"title3":"Coronavirus%20disease%202019%20in%20elderly%20patients:%20Characteristics%20and%20prognostic%20factors%20based%20on%204-week%20follow-up"},{"title3":"Coronavirus%20disease%202019%20in%20elderly%20patients:%20Characteristics%20and%20prognostic%20factors%20based%20on%204-week%20follow-up"},{"title3":"Coronavirus%20disease%202019%20in%20elderly%20patients:%20Characteristics%20and%20prognostic%20factors%20based%20on%204-week%20follow-up"},{"title3":"Coronavirus%20disease%202019%20in%20elderly%20patients:%20Characteristics%20and%20prognostic%20factors%20based%20on%204-week%20follow-up"},{"title3":"Coronavirus%20disease%202019%20in%20elderly%20patients:%20Characteristics%20and%20prognostic%20factors%20based%20on%204-week%20follow-up"},{"title3":"Coronavirus%20disease%202019%20in%20elderly%20patients:%20Characteristics%20and%20prognostic%20factors%20based%20on%204-week%20follow-up"},{"title3":"Coronavirus%20disease%202019%20in%20elderly%20patients:%20Characteristics%20and%20prognostic%20factors%20based%20on%204-week%20follow-up"},{"title3":"Coronavirus%20disease%202019%20in%20elderly%20patients:%20Characteristics%20and%20prognostic%20factors%20based%20on%204-week%20follow-up"},{"title3":"Coronavirus%20disease%202019%20in%20elderly%20patients:%20Characteristics%20and%20prognostic%20factors%20based%20on%204-week%20follow-up"},{"title3":"Coronavirus%20disease%202019%20in%20elderly%20patients:%20Characteristics%20and%20prognostic%20factors%20based%20on%204-week%20follow-up"}]},{"title2":"Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers","References":[{"title3":"Comorbidities%20in%20COVID-19:%20Outcomes%20in%20hypertensive%20cohort%20and%20controversies%20with%20renin%20angiotensin%20system%20blockers"},{"title3":"Comorbidities%20in%20COVID-19:%20Outcomes%20in%20hypertensive%20cohort%20and%20controversies%20with%20renin%20angiotensin%20system%20blockers"},{"title3":"Comorbidities%20in%20COVID-19:%20Outcomes%20in%20hypertensive%20cohort%20and%20controversies%20with%20renin%20angiotensin%20system%20blockers"},{"title3":"Comorbidities%20in%20COVID-19:%20Outcomes%20in%20hypertensive%20cohort%20and%20controversies%20with%20renin%20angiotensin%20system%20blockers"}]},{"title2":"Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms","References":[]},{"title2":"Epidemiological characteristics of COVID-19 cases in Italy and estimates of the reproductive numbers one month into the epidemic","References":[]},{"title2":"World Health Organization (WHO). Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. 2020; https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected","References":[]},{"title2":"D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19","References":[{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"},{"title3":"D-dimer%20levels%20on%20admission%20to%20predict%20in-hospital%20mortality%20in%20patients%20with%20Covid-19"}]},{"title2":"COVID-19 and its implications for thrombosis and anticoagulation","References":[]}]},{"title1":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","References":[{"title2":"Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"}]},{"title2":"Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis","References":[{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"},{"title3":"Chinese%20society%20of%20cardiology%20expert%20consensus%20statement%20on%20the%20diagnosis%20and%20treatment%20of%20adult%20fulminant%20myocarditis"}]}]},{"title1":"Characteristics and clinical outcomes of COVID?19 patients in an underserved?inner city population: A single tertiary center cohort","References":[{"title2":"Novel coronavirus:China","References":[]},{"title2":"  . 2020. COVID-19 Map. [online] Available at: &lt;https://coronavirus.jhu.edu/map.html&gt; Accessed May 2, 2020.","References":[]},{"title2":" https://www.inquirer.com/news/coronavirus-nursing-homes-philadelphia-data-farley-deaths-rates-20200503.html ","References":[]},{"title2":"  One Month Inside a Philly Hospital on the Front Lines of the COVID-19 Pandemic [Internet]. Philadelphia Magazine. Philadelphia Magazine; 2020 [cited 2020 Jun 14]. Available from: https://www.phillymag.com/news/2020/04/25/einstein-medical-center-coronavirus/. Accessed June 14, 2020.","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"}]},{"title2":"Covid-19 in critically ill patients in the Seattle region:case series","References":[{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region:case%20series"}]},{"title2":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State","References":[]},{"title2":"Presenting Characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area","References":[]},{"title2":"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York","References":[{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"},{"title3":"Severe%20obesity%20is%20associated%20with%20higher%20in-hospital%20mortality%20in%20a%20cohort%20of%20patients%20with%20COVID-19%20in%20the%20Bronx,%20New%20York"}]},{"title2":"Distinct component profiles and high risk among african americans with metabolic syndrome","References":[]},{"title2":"The immunopathogenesis of sepsis in elderly patients","References":[]},{"title2":"Obesity and COVID-19 severity in a designated hospital in Shenzhen, China","References":[]},{"title2":"Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease","References":[{"title3":"Obesity%20as%20a%20risk%20factor%20for%20greater%20severity%20of%20COVID-19%20in%20patients%20with%20metabolic%20associated%20fatty%20liver%20disease"},{"title3":"Obesity%20as%20a%20risk%20factor%20for%20greater%20severity%20of%20COVID-19%20in%20patients%20with%20metabolic%20associated%20fatty%20liver%20disease"},{"title3":"Obesity%20as%20a%20risk%20factor%20for%20greater%20severity%20of%20COVID-19%20in%20patients%20with%20metabolic%20associated%20fatty%20liver%20disease"},{"title3":"Obesity%20as%20a%20risk%20factor%20for%20greater%20severity%20of%20COVID-19%20in%20patients%20with%20metabolic%20associated%20fatty%20liver%20disease"},{"title3":"Obesity%20as%20a%20risk%20factor%20for%20greater%20severity%20of%20COVID-19%20in%20patients%20with%20metabolic%20associated%20fatty%20liver%20disease"},{"title3":"Obesity%20as%20a%20risk%20factor%20for%20greater%20severity%20of%20COVID-19%20in%20patients%20with%20metabolic%20associated%20fatty%20liver%20disease"},{"title3":"Obesity%20as%20a%20risk%20factor%20for%20greater%20severity%20of%20COVID-19%20in%20patients%20with%20metabolic%20associated%20fatty%20liver%20disease"},{"title3":"Obesity%20as%20a%20risk%20factor%20for%20greater%20severity%20of%20COVID-19%20in%20patients%20with%20metabolic%20associated%20fatty%20liver%20disease"},{"title3":"Obesity%20as%20a%20risk%20factor%20for%20greater%20severity%20of%20COVID-19%20in%20patients%20with%20metabolic%20associated%20fatty%20liver%20disease"},{"title3":"Obesity%20as%20a%20risk%20factor%20for%20greater%20severity%20of%20COVID-19%20in%20patients%20with%20metabolic%20associated%20fatty%20liver%20disease"}]},{"title2":"Physiology of obesity and effects on lung function","References":[]},{"title2":"Obesity and infection","References":[{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"},{"title3":"Obesity%20and%20infection"}]},{"title2":"COVID-19 and African Americans","References":[{"title3":"COVID-19%20and%20African%20Americans"},{"title3":"COVID-19%20and%20African%20Americans"},{"title3":"COVID-19%20and%20African%20Americans"},{"title3":"COVID-19%20and%20African%20Americans"},{"title3":"COVID-19%20and%20African%20Americans"},{"title3":"COVID-19%20and%20African%20Americans"},{"title3":"COVID-19%20and%20African%20Americans"},{"title3":"COVID-19%20and%20African%20Americans"},{"title3":"COVID-19%20and%20African%20Americans"},{"title3":"COVID-19%20and%20African%20Americans"},{"title3":"COVID-19%20and%20African%20Americans"}]},{"title2":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients","References":[]},{"title2":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome","References":[]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","References":[]},{"title2":"Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial","References":[{"title3":"Hydroxychloroquine%20in%20patients%20with%20COVID-19:%20an%20open-label,%20randomized,%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20COVID-19:%20an%20open-label,%20randomized,%20controlled%20trial"},{"title3":"Hydroxychloroquine%20in%20patients%20with%20COVID-19:%20an%20open-label,%20randomized,%20controlled%20trial"}]},{"title2":"No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection","References":[{"title3":"No%20evidence%20of%20rapid%20antiviral%20clearance%20or%20clinical%20benefit%20with%20the%20combination%20of%20hydroxychloroquine%20and%20azithromycin%20in%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"No%20evidence%20of%20rapid%20antiviral%20clearance%20or%20clinical%20benefit%20with%20the%20combination%20of%20hydroxychloroquine%20and%20azithromycin%20in%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"No%20evidence%20of%20rapid%20antiviral%20clearance%20or%20clinical%20benefit%20with%20the%20combination%20of%20hydroxychloroquine%20and%20azithromycin%20in%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"No%20evidence%20of%20rapid%20antiviral%20clearance%20or%20clinical%20benefit%20with%20the%20combination%20of%20hydroxychloroquine%20and%20azithromycin%20in%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"No%20evidence%20of%20rapid%20antiviral%20clearance%20or%20clinical%20benefit%20with%20the%20combination%20of%20hydroxychloroquine%20and%20azithromycin%20in%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"No%20evidence%20of%20rapid%20antiviral%20clearance%20or%20clinical%20benefit%20with%20the%20combination%20of%20hydroxychloroquine%20and%20azithromycin%20in%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"No%20evidence%20of%20rapid%20antiviral%20clearance%20or%20clinical%20benefit%20with%20the%20combination%20of%20hydroxychloroquine%20and%20azithromycin%20in%20patients%20with%20severe%20COVID-19%20infection"},{"title3":"No%20evidence%20of%20rapid%20antiviral%20clearance%20or%20clinical%20benefit%20with%20the%20combination%20of%20hydroxychloroquine%20and%20azithromycin%20in%20patients%20with%20severe%20COVID-19%20infection"}]},{"title2":"Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19","References":[{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"},{"title3":"Outcomes%20of%20hydroxychloroquine%20usage%20in%20United%20States%20veterans%20hospitalized%20with%20Covid-19"}]},{"title2":"Effective treatment of severe COVID-19 patients with tocilizumab","References":[{"title3":"Effective%20treatment%20of%20severe%20COVID-19%20patients%20with%20tocilizumab"},{"title3":"Effective%20treatment%20of%20severe%20COVID-19%20patients%20with%20tocilizumab"},{"title3":"Effective%20treatment%20of%20severe%20COVID-19%20patients%20with%20tocilizumab"},{"title3":"Effective%20treatment%20of%20severe%20COVID-19%20patients%20with%20tocilizumab"},{"title3":"Effective%20treatment%20of%20severe%20COVID-19%20patients%20with%20tocilizumab"},{"title3":"Effective%20treatment%20of%20severe%20COVID-19%20patients%20with%20tocilizumab"},{"title3":"Effective%20treatment%20of%20severe%20COVID-19%20patients%20with%20tocilizumab"},{"title3":"Effective%20treatment%20of%20severe%20COVID-19%20patients%20with%20tocilizumab"},{"title3":"Effective%20treatment%20of%20severe%20COVID-19%20patients%20with%20tocilizumab"},{"title3":"Effective%20treatment%20of%20severe%20COVID-19%20patients%20with%20tocilizumab"},{"title3":"Effective%20treatment%20of%20severe%20COVID-19%20patients%20with%20tocilizumab"},{"title3":"Effective%20treatment%20of%20severe%20COVID-19%20patients%20with%20tocilizumab"},{"title3":"Effective%20treatment%20of%20severe%20COVID-19%20patients%20with%20tocilizumab"},{"title3":"Effective%20treatment%20of%20severe%20COVID-19%20patients%20with%20tocilizumab"},{"title3":"Effective%20treatment%20of%20severe%20COVID-19%20patients%20with%20tocilizumab"},{"title3":"Effective%20treatment%20of%20severe%20COVID-19%20patients%20with%20tocilizumab"},{"title3":"Effective%20treatment%20of%20severe%20COVID-19%20patients%20with%20tocilizumab"},{"title3":"Effective%20treatment%20of%20severe%20COVID-19%20patients%20with%20tocilizumab"},{"title3":"Effective%20treatment%20of%20severe%20COVID-19%20patients%20with%20tocilizumab"}]},{"title2":"Tocilizumab treatment in COVID-19: a single center experience","References":[{"title3":"Tocilizumab%20treatment%20in%20COVID-19:%20a%20single%20center%20experience"},{"title3":"Tocilizumab%20treatment%20in%20COVID-19:%20a%20single%20center%20experience"},{"title3":"Tocilizumab%20treatment%20in%20COVID-19:%20a%20single%20center%20experience"},{"title3":"Tocilizumab%20treatment%20in%20COVID-19:%20a%20single%20center%20experience"},{"title3":"Tocilizumab%20treatment%20in%20COVID-19:%20a%20single%20center%20experience"},{"title3":"Tocilizumab%20treatment%20in%20COVID-19:%20a%20single%20center%20experience"},{"title3":"Tocilizumab%20treatment%20in%20COVID-19:%20a%20single%20center%20experience"},{"title3":"Tocilizumab%20treatment%20in%20COVID-19:%20a%20single%20center%20experience"},{"title3":"Tocilizumab%20treatment%20in%20COVID-19:%20a%20single%20center%20experience"},{"title3":"Tocilizumab%20treatment%20in%20COVID-19:%20a%20single%20center%20experience"},{"title3":"Tocilizumab%20treatment%20in%20COVID-19:%20a%20single%20center%20experience"},{"title3":"Tocilizumab%20treatment%20in%20COVID-19:%20a%20single%20center%20experience"},{"title3":"Tocilizumab%20treatment%20in%20COVID-19:%20a%20single%20center%20experience"},{"title3":"Tocilizumab%20treatment%20in%20COVID-19:%20a%20single%20center%20experience"},{"title3":"Tocilizumab%20treatment%20in%20COVID-19:%20a%20single%20center%20experience"},{"title3":"Tocilizumab%20treatment%20in%20COVID-19:%20a%20single%20center%20experience"},{"title3":"Tocilizumab%20treatment%20in%20COVID-19:%20a%20single%20center%20experience"},{"title3":"Tocilizumab%20treatment%20in%20COVID-19:%20a%20single%20center%20experience"},{"title3":"Tocilizumab%20treatment%20in%20COVID-19:%20a%20single%20center%20experience"},{"title3":"Tocilizumab%20treatment%20in%20COVID-19:%20a%20single%20center%20experience"},{"title3":"Tocilizumab%20treatment%20in%20COVID-19:%20a%20single%20center%20experience"},{"title3":"Tocilizumab%20treatment%20in%20COVID-19:%20a%20single%20center%20experience"}]},{"title2":"COVID-19 cytokine storm: the interplay between inflammation and coagulation","References":[{"title3":"COVID-19%20cytokine%20storm:%20the%20interplay%20between%20inflammation%20and%20coagulation"},{"title3":"COVID-19%20cytokine%20storm:%20the%20interplay%20between%20inflammation%20and%20coagulation"},{"title3":"COVID-19%20cytokine%20storm:%20the%20interplay%20between%20inflammation%20and%20coagulation"},{"title3":"COVID-19%20cytokine%20storm:%20the%20interplay%20between%20inflammation%20and%20coagulation"},{"title3":"COVID-19%20cytokine%20storm:%20the%20interplay%20between%20inflammation%20and%20coagulation"},{"title3":"COVID-19%20cytokine%20storm:%20the%20interplay%20between%20inflammation%20and%20coagulation"},{"title3":"COVID-19%20cytokine%20storm:%20the%20interplay%20between%20inflammation%20and%20coagulation"},{"title3":"COVID-19%20cytokine%20storm:%20the%20interplay%20between%20inflammation%20and%20coagulation"},{"title3":"COVID-19%20cytokine%20storm:%20the%20interplay%20between%20inflammation%20and%20coagulation"},{"title3":"COVID-19%20cytokine%20storm:%20the%20interplay%20between%20inflammation%20and%20coagulation"},{"title3":"COVID-19%20cytokine%20storm:%20the%20interplay%20between%20inflammation%20and%20coagulation"},{"title3":"COVID-19%20cytokine%20storm:%20the%20interplay%20between%20inflammation%20and%20coagulation"}]}]},{"title1":"Scoring systems for predicting mortality for severe patients with COVID-19","References":[{"title2":"The novel coronavirus originating in Wuhan, China: challenges for global health governance","References":[]},{"title2":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","References":[{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"},{"title3":"The%20species%20severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"}]},{"title2":"Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate","References":[]},{"title2":"Strategies to control COVID-19 and future pandemics in Africa and around the globe","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"}]},{"title2":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan","References":[{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"},{"title3":"Risk%20factors%20for%20severity%20and%20mortality%20in%20adult%20COVID-19%20inpatients%20in%20Wuhan"}]},{"title2":"A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy","References":[{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"},{"title3":"A%20European%20Renal%20Best%20Practice%20(ERBP)%20position%20statement%20on%20the%20Kidney%20Disease%20Improving%20Global%20Outcomes%20(KDIGO)%20clinical%20practice%20guidelines%20on%20acute%20kidney%20injury:%20part%201:%20definitions,%20conservative%20management%20and%20contrast-induced%20nephropathy"}]},{"title2":"Definition and classification of kidney diseases","References":[]},{"title2":"Criteria of drug-induced liver disorders. Report of an international consensus meeting","References":[]},{"title2":"Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury","References":[{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"},{"title3":"Definition%20and%20risk%20factors%20for%20chronicity%20following%20acute%20idiosyncratic%20drug-induced%20liver%20injury"}]},{"title2":"Kidney disease is associated with in-hospital death of patients with COVID-19","References":[]},{"title2":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","References":[]},{"title2":"Liver injury in COVID-19: management and challenges","References":[{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"}]},{"title2":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","References":[{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"}]},{"title2":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection","References":[{"title3":"Single-cell%20RNA-seq%20data%20analysis%20on%20the%20receptor%20ACE2%20expression%20reveals%20the%20potential%20risk%20of%20different%20human%20organs%20vulnerable%20to%202019-nCoV%20infection"},{"title3":"Single-cell%20RNA-seq%20data%20analysis%20on%20the%20receptor%20ACE2%20expression%20reveals%20the%20potential%20risk%20of%20different%20human%20organs%20vulnerable%20to%202019-nCoV%20infection"},{"title3":"Single-cell%20RNA-seq%20data%20analysis%20on%20the%20receptor%20ACE2%20expression%20reveals%20the%20potential%20risk%20of%20different%20human%20organs%20vulnerable%20to%202019-nCoV%20infection"},{"title3":"Single-cell%20RNA-seq%20data%20analysis%20on%20the%20receptor%20ACE2%20expression%20reveals%20the%20potential%20risk%20of%20different%20human%20organs%20vulnerable%20to%202019-nCoV%20infection"},{"title3":"Single-cell%20RNA-seq%20data%20analysis%20on%20the%20receptor%20ACE2%20expression%20reveals%20the%20potential%20risk%20of%20different%20human%20organs%20vulnerable%20to%202019-nCoV%20infection"},{"title3":"Single-cell%20RNA-seq%20data%20analysis%20on%20the%20receptor%20ACE2%20expression%20reveals%20the%20potential%20risk%20of%20different%20human%20organs%20vulnerable%20to%202019-nCoV%20infection"},{"title3":"Single-cell%20RNA-seq%20data%20analysis%20on%20the%20receptor%20ACE2%20expression%20reveals%20the%20potential%20risk%20of%20different%20human%20organs%20vulnerable%20to%202019-nCoV%20infection"},{"title3":"Single-cell%20RNA-seq%20data%20analysis%20on%20the%20receptor%20ACE2%20expression%20reveals%20the%20potential%20risk%20of%20different%20human%20organs%20vulnerable%20to%202019-nCoV%20infection"},{"title3":"Single-cell%20RNA-seq%20data%20analysis%20on%20the%20receptor%20ACE2%20expression%20reveals%20the%20potential%20risk%20of%20different%20human%20organs%20vulnerable%20to%202019-nCoV%20infection"},{"title3":"Single-cell%20RNA-seq%20data%20analysis%20on%20the%20receptor%20ACE2%20expression%20reveals%20the%20potential%20risk%20of%20different%20human%20organs%20vulnerable%20to%202019-nCoV%20infection"},{"title3":"Single-cell%20RNA-seq%20data%20analysis%20on%20the%20receptor%20ACE2%20expression%20reveals%20the%20potential%20risk%20of%20different%20human%20organs%20vulnerable%20to%202019-nCoV%20infection"},{"title3":"Single-cell%20RNA-seq%20data%20analysis%20on%20the%20receptor%20ACE2%20expression%20reveals%20the%20potential%20risk%20of%20different%20human%20organs%20vulnerable%20to%202019-nCoV%20infection"},{"title3":"Single-cell%20RNA-seq%20data%20analysis%20on%20the%20receptor%20ACE2%20expression%20reveals%20the%20potential%20risk%20of%20different%20human%20organs%20vulnerable%20to%202019-nCoV%20infection"},{"title3":"Single-cell%20RNA-seq%20data%20analysis%20on%20the%20receptor%20ACE2%20expression%20reveals%20the%20potential%20risk%20of%20different%20human%20organs%20vulnerable%20to%202019-nCoV%20infection"},{"title3":"Single-cell%20RNA-seq%20data%20analysis%20on%20the%20receptor%20ACE2%20expression%20reveals%20the%20potential%20risk%20of%20different%20human%20organs%20vulnerable%20to%202019-nCoV%20infection"},{"title3":"Single-cell%20RNA-seq%20data%20analysis%20on%20the%20receptor%20ACE2%20expression%20reveals%20the%20potential%20risk%20of%20different%20human%20organs%20vulnerable%20to%202019-nCoV%20infection"},{"title3":"Single-cell%20RNA-seq%20data%20analysis%20on%20the%20receptor%20ACE2%20expression%20reveals%20the%20potential%20risk%20of%20different%20human%20organs%20vulnerable%20to%202019-nCoV%20infection"},{"title3":"Single-cell%20RNA-seq%20data%20analysis%20on%20the%20receptor%20ACE2%20expression%20reveals%20the%20potential%20risk%20of%20different%20human%20organs%20vulnerable%20to%202019-nCoV%20infection"},{"title3":"Single-cell%20RNA-seq%20data%20analysis%20on%20the%20receptor%20ACE2%20expression%20reveals%20the%20potential%20risk%20of%20different%20human%20organs%20vulnerable%20to%202019-nCoV%20infection"}]},{"title2":"Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: a retrospective study","References":[{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"},{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"},{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"},{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"},{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"},{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"},{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"},{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"},{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"},{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"},{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"},{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"}]},{"title2":"Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis","References":[{"title3":"Identification%20of%20a%20potential%20mechanism%20of%20acute%20kidney%20injury%20during%20the%20COVID-19%20outbreak:%20a%20study%20based%20on%20single-cell%20transcriptome%20analysis"},{"title3":"Identification%20of%20a%20potential%20mechanism%20of%20acute%20kidney%20injury%20during%20the%20COVID-19%20outbreak:%20a%20study%20based%20on%20single-cell%20transcriptome%20analysis"},{"title3":"Identification%20of%20a%20potential%20mechanism%20of%20acute%20kidney%20injury%20during%20the%20COVID-19%20outbreak:%20a%20study%20based%20on%20single-cell%20transcriptome%20analysis"},{"title3":"Identification%20of%20a%20potential%20mechanism%20of%20acute%20kidney%20injury%20during%20the%20COVID-19%20outbreak:%20a%20study%20based%20on%20single-cell%20transcriptome%20analysis"},{"title3":"Identification%20of%20a%20potential%20mechanism%20of%20acute%20kidney%20injury%20during%20the%20COVID-19%20outbreak:%20a%20study%20based%20on%20single-cell%20transcriptome%20analysis"},{"title3":"Identification%20of%20a%20potential%20mechanism%20of%20acute%20kidney%20injury%20during%20the%20COVID-19%20outbreak:%20a%20study%20based%20on%20single-cell%20transcriptome%20analysis"}]},{"title2":"Predictors of mortality in Middle East respiratory syndrome (MERS)","References":[{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"}]},{"title2":"Clinical predictors of mortality of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: a cohort study","References":[{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"},{"title3":"Clinical%20predictors%20of%20mortality%20of%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20(MERS-CoV)%20infection:%20a%20cohort%20study"}]},{"title2":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong","References":[]},{"title2":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)","References":[]},{"title2":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","References":[{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"}]},{"title2":"Acute pneumonia and the cardiovascular system","References":[]},{"title2":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015","References":[{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"}]},{"title2":"An interferon-gamma-related cytokine storm in SARS patients","References":[{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"}]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"}]},{"title2":"Middle east respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways","References":[]},{"title2":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV","References":[{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"},{"title3":"T-cell%20immunity%20of%20SARS-CoV:%20implications%20for%20vaccine%20development%20against%20MERS-CoV"}]},{"title2":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study","References":[{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"},{"title3":"Temporal%20profiles%20of%20viral%20load%20in%20posterior%20oropharyngeal%20saliva%20samples%20and%20serum%20antibody%20responses%20during%20infection%20by%20SARS-CoV-2:%20an%20observational%20cohort%20study"}]},{"title2":"Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019","References":[{"title3":"Diagnostic%20value%20and%20dynamic%20variance%20of%20serum%20antibody%20in%20coronavirus%20disease%202019"},{"title3":"Diagnostic%20value%20and%20dynamic%20variance%20of%20serum%20antibody%20in%20coronavirus%20disease%202019"},{"title3":"Diagnostic%20value%20and%20dynamic%20variance%20of%20serum%20antibody%20in%20coronavirus%20disease%202019"},{"title3":"Diagnostic%20value%20and%20dynamic%20variance%20of%20serum%20antibody%20in%20coronavirus%20disease%202019"},{"title3":"Diagnostic%20value%20and%20dynamic%20variance%20of%20serum%20antibody%20in%20coronavirus%20disease%202019"},{"title3":"Diagnostic%20value%20and%20dynamic%20variance%20of%20serum%20antibody%20in%20coronavirus%20disease%202019"},{"title3":"Diagnostic%20value%20and%20dynamic%20variance%20of%20serum%20antibody%20in%20coronavirus%20disease%202019"},{"title3":"Diagnostic%20value%20and%20dynamic%20variance%20of%20serum%20antibody%20in%20coronavirus%20disease%202019"},{"title3":"Diagnostic%20value%20and%20dynamic%20variance%20of%20serum%20antibody%20in%20coronavirus%20disease%202019"},{"title3":"Diagnostic%20value%20and%20dynamic%20variance%20of%20serum%20antibody%20in%20coronavirus%20disease%202019"}]},{"title2":"Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019","References":[]},{"title2":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","References":[]},{"title2":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile","References":[{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"}]},{"title2":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS","References":[{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"}]},{"title2":"Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus","References":[{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"},{"title3":"Cell%20host%20response%20to%20infection%20with%20novel%20human%20coronavirus%20EMC%20predicts%20potential%20antivirals%20and%20important%20differences%20with%20SARS%20coronavirus"}]},{"title2":"Critical care management of adults with community-acquired severe respiratory viral infection","References":[{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"},{"title3":"Critical%20care%20management%20of%20adults%20with%20community-acquired%20severe%20respiratory%20viral%20infection"}]},{"title2":"Early use of glucocorticoids was a risk factor for critical disease and death from pH1N1 infection","References":[]},{"title2":"Systemic corticosteroid therapy may delay viral clearance in patients with middle east respiratory syndrome coronavirus infection","References":[]},{"title2":"Corticosteroid therapy for critically ill patients with middle east respiratory syndrome","References":[]},{"title2":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients","References":[]},{"title2":"The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness","References":[{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"},{"title3":"The%20influence%20of%20corticosteroid%20treatment%20on%20the%20outcome%20of%20influenza%20A(H1N1pdm09)-related%20critical%20illness"}]},{"title2":"Clinical and immunologic features in severe and moderate coronavirus disease 2019","References":[]},{"title2":"Interleukin-6 use in COVID-19 pneumonia related macrophage activation syndrome","References":[]}]}]}